Clinical Effectiveness of Jyotismati taila(Celastrus Paniculatus) in Mild Cognitive Impairment of the elderly

Effectiveness of Jyotismati taila (Celastrus Panniculatus)in Mild Cognitive Impairment of the elderly

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020980

Enrollment

Registered

2019-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G311- Senile degeneration of brain, notelsewhere classified

Interventions

Intervention1: an open labeled single arm exploratory clinical trial of Jyotismati taila( CELASTRUS PANICULATUS) in mild cognitive impairment of the elderly: Diagnosed subjects who fulfill the inclusi

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of above 60 years of age Irrespective of gender and socio-economic status Diagnosed subjects who are ready to sign the informed consent form History of Diabetes & Hypertension who are under medication without complications

Exclusion criteria

Exclusion criteria: Subjects who have reduced cognitive functions as a result to any other organic lesions and to acute viral and bacterial infection etc. Subjects suffering from complicated condition of systemic disorders.

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of Jyotismathi taila in the symptoms of mild cognitive impairment of the elderly.Timepoint: Assessment will be done on baseline, 15th, 30th and 45th day	—

Secondary

Measure	Time frame
Quality of lifeTimepoint: Assessment will be done on baseline, 15th, 30th and 45th day	—

Countries

India

Contacts

Public ContactDr Deena Dayalan S

Sri Dharmasthala college of Ayurveda and Hospital

mr@sdmcahhassan.org9449603234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026